Related Experiment Video
Updated: Aug 9, 2026

Determining Genetic Expression Profiles in C. elegans Using Microarray and Real-time PCR
Published on: July 30, 2011
A component of the transcriptional mediator complex inhibits RAS-dependent vulval fate specification in C. elegans
Nadeem Moghal1, Paul W Sternberg
1Howard Hughes Medical Institute, and Division of Biology, California Institute of Technology, Pasadena, CA 91125, USA.
Abstract:
Negative regulation of receptor tyrosine kinase (RTK)/RAS signaling pathways is important for normal development and the prevention of disease in humans. We have used a genetic screen in C. elegans to identify genes that antagonize the activity of activated LET-23, a member of the EGFR family of RTKs. We identified two loss-of-function mutations in dpy-22, previously cloned as sop-1, that promote the ability of activated LET-23 to induce ectopic vulval fates. DPY-22 is a glutamine-rich protein that is most similar to human TRAP230, a component of a transcriptional mediator complex. DPY-22 has previously been shown to regulate WNT responses through inhibition of the beta-catenin-like protein BAR-1. We provide evidence that DPY-22 also inhibits RAS-dependent vulval fate specification independently of BAR-1, and probably regulates the activities of multiple transcription factors during development. Furthermore, we demonstrate that although inhibition of BAR-1-dependent gene expression has been shown to require the C-terminal glutamine-rich region, this region is dispensable for inhibition of RAS-dependent cell differentiation. Thus, the glutamine-rich region contributes to specificity of this class of mediator protein.
Insights
DPY-22 antagonizes receptor tyrosine kinase (RTK) signaling in C. elegans development. This protein inhibits RAS-dependent cell differentiation independently of BAR-1, highlighting its role in developmental pathway regulation.
Area of Science:
- Developmental Biology
- Molecular Biology
- Genetics
Background:
- Receptor tyrosine kinase (RTK)/RAS signaling pathways are crucial for human development and disease prevention.
- Negative regulation of these pathways is essential for maintaining normal biological processes.
Purpose of the Study:
- To identify genes that antagonize activated LET-23, an epidermal growth factor receptor (EGFR) family member, using a genetic screen in C. elegans.
- To investigate the role of DPY-22 in regulating RTK/RAS signaling pathways.
Main Methods:
- Genetic screening in C. elegans to identify mutations affecting LET-23 activity.
- Characterization of dpy-22 loss-of-function mutations.
- Analysis of DPY-22's interaction with BAR-1 and RAS-dependent pathways.
Main Results:
- Two loss-of-function mutations in dpy-22 (sop-1) were identified, enhancing activated LET-23 signaling and inducing ectopic vulval fates.
- DPY-22, similar to human TRAP230, inhibits RAS-dependent vulval fate specification independently of BAR-1.
- The C-terminal glutamine-rich region of DPY-22 is dispensable for inhibiting RAS-dependent cell differentiation, suggesting a role in specificity.
Conclusions:
- DPY-22 acts as a negative regulator of RTK/RAS signaling in C. elegans development.
- DPY-22's function in inhibiting RAS-dependent cell differentiation is distinct from its role in WNT/BAR-1 signaling.
- The glutamine-rich region of DPY-22 contributes to the specificity of this transcriptional mediator protein class.
Related Concept Videos
RNA Polymerase II Accessory Proteins
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Master Transcription Regulators
The Ras Gene
Ras is a superfamily...
MAPK Signaling Cascades
Transcriptional Regulation: Riboswitches

